openPR Logo
Press release

Primary Progressive Multiple Sclerosis Market to Witness Exponential Growth by 2024

03-13-2018 01:40 PM CET | Health & Medicine

Press release from: Transparency Market Research

Primary Progressive Multiple Sclerosis Market to Witness

Multiple sclerosis (MS), which is also referred as disseminated sclerosis, is an inflammatory disease of the nervous system. It is mainly characterized by the disruption of the nerve cells of the spinal cord and the brain of an affected individual, which results in the loss of ability to communicate along with various other physical, mental as well as psychiatric problems. Primary progressive multiple sclerosis (PPMS) is a type of MS in which the neurological functioning steadily deteriorates with no distinct relapses (also known as attacks or exacerbations) or fixed period of remissions. The rate of progression of PPMS may differ from person to person as well as over time, that may show signs of temporary improvement, however, the disease progression remains consistent.

At present, several forms of relapsing MS are increasingly affecting large number of individuals worldwide, such as, secondary-progressive MS, relapsing remitting MS, progressive relapsing MS and primary progressive MS. These individuals continuously experience relapses, which are distinct inflammatory attacks mainly on the myelin sheath of the nerve fibers. In addition, PPMS is characterized by least inflammation among different types of relapsing MS. PPMS also results in very fewer brain lesions or plaques than in patients with other forms of relapsing MS; these lesions also contain very small amount inflammatory cells. Individuals suffering from PPMS have more lesions on spinal cord than the brain. Thus, these differences have made PPMS difficult to diagnose as well as treat than other forms of relapsing MS.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3016

At present, different diagnostic tests are being utilized for effectively diagnosing and employing proper treatment procedure in place. Some of the diagnostic tests include Magnetic Resonance Imaging (MRI) Scans, Lumbar Puncture and other simple electrical stimulation tests. Major therapeutics available for the symptomatic treatment of PPMS include Baclofen, Dantrolene, Oxybutynin, Detrusitol, Amantadine, Modafinil, Clonazepam, Gabapentin and Pregabalin. However, several manufacturers are developing specific PPMS treatment drugs which are in different stages of clinical trials, which include Fingolimod and Masitinib.

Some of the major driving factors for the growth of Primary Progressive Multiple Sclerosis Market include increasing prevalence of neurological disorders, rising demand for advanced therapeutics for the treatment of PPMS and increasing awareness and affordability of the population in developing nations. Multiple sclerosis is the most widespread neurological disorder that affects individuals of any age, but is mainly diagnosed between 20 to 40 years of age.

Request to View ToC of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=3016

According to multiplesclerosis.net (Health Union, U.S.), there are more than 2.5 million people suffering from multiple sclerosis, which are at different stages of the disease. Among all forms of MS, 10% to 15% individuals suffer from PPMS, which are difficult to diagnose as well as treat; hence, high demand for advanced therapeutics for its treatment will further boost the growth of this market.

Geographically, North America and Europe are expected to dominate the PPMS market. Major factors that can be responsible for their dominance in this market are high prevalence of MS and high demand for therapeutic drugs for effective treatment of PPMS in these regions. According to multiplesclerosis.net more than 500,000 people suffer from MS in Europe and around 400,000 people suffer from it only in the U.S. Thus, high prevalence rate of MS and PPMS will contribute towards the growth of this market in the region. Some of the major players having their drugs for SPMS in different phases of clinical trials, include, F. Hoffmann-La Roche Ltd. and Innate Immunotherapeutics Limited.

View Report -

https://www.transparencymarketresearch.com/primary-progressive-multiple-sclerosis.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Primary Progressive Multiple Sclerosis Market to Witness Exponential Growth by 2024 here

News-ID: 976757 • Views:

More Releases from Transparency Market Research

From USD 273.8 Million to USD 2.2 Billion: The Rise of Alternate Marine Power by 2034
From USD 273.8 Million to USD 2.2 Billion: The Rise of Alternate Marine Power by …
The global alternate marine power market (alternativer Markt für Meeresenergie), valued at US$ 273.8 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 8.1% from 2024 to 2034, reaching an estimated US$ 2.2 billion by the end of the forecast period. Download Sample Report Copy Here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=37190&utm_source=OpenPR_Sandeep&utm_medium=OpenPR Analyst Viewpoint The increasing focus on environmental sustainability is significantly enhancing the market value of alternate marine power. Stakeholders in
Battery Pack for Marine Hybrid & Full Electric Propulsion Market Set to Reach USD 2.4 Billion by 2034
Battery Pack for Marine Hybrid & Full Electric Propulsion Market Set to Reach US …
The global battery pack for marine hybrid and full electric propulsion market, valued at US$ 977.6 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 8.7% from 2024 to 2034, reaching an estimated US$ 2.4 billion by the end of the forecast period. Download Sample Report Copy Here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=76884&utm_source=OpenPR_Sandeep&utm_medium=OpenPR Analyst Viewpoint The rise in electrification within the marine sector is significantly boosting the market. Traditional fuel sources
Drinking Water Pipe Repair Market to Surpass USD 128.5 Bn by 2031: Growth Insights
Drinking Water Pipe Repair Market to Surpass USD 128.5 Bn by 2031: Growth Insigh …
The global drinking water pipe repair market was valued at USD 71.1 billion in 2022 and is projected to reach USD 128.5 billion by the end of 2031, growing at a compound annual growth rate (CAGR) of 6.8% from 2023 to 2031. This robust growth is driven by increasing concerns about water scarcity, rapid urbanization, and the aging infrastructure in many developed and developing countries. Download Sample Report Copy Here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=48420&utm_source=OpenPR_Sandeep&utm_medium=OpenPR Analyst
Future of Well Testing Services Market: From USD 7.6 Bn in 2022 to USD 13.3 Bn by 2031
Future of Well Testing Services Market: From USD 7.6 Bn in 2022 to USD 13.3 Bn b …
The global well testing services market was valued at US$ 7.6 billion in 2022 and is projected to reach US$ 13.3 billion by the end of 2031, growing at a CAGR of 6.4% from 2023 to 2031. The market is witnessing robust growth driven by the increasing demand for non-conventional energy sources and the rising adoption of advanced technologies for efficient well management. Download Sample Report Copy Here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=48234&utm_source=OpenPR_Sandeep&utm_medium=OpenPR Key Market Drivers Adoption

All 5 Releases


More Releases for PPMS

Primary Progressive Multiple Sclerosis Market Size, Share, Epidemiology, Drugs, …
DelveInsight's "Primary Progressive Multiple Sclerosis (PPMS) - Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Primary Progressive Multiple Sclerosis (PPMS), historical and forecasted epidemiology as well as the Primary Progressive Multiple Sclerosis (PPMS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To know more about Primary Progressive Multiple Sclerosis, Click here: https://www.delveinsight.com/report-store/primary-progressive-multiple-sclerosis-ppms-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr Some facts of the Primary Progressive Multiple
PPMS and SPMS: Epidemiology and Market Forecasts to 2030
Multiple Sclerosis is an autoimmune disorder that happens in the Central nervous system of the body. Multiple Sclerosis involves the brain, optic nerves and the spinal cord and leads to the destruction of the insulation layer, Myelin, which covers the nerve fibers in the CNS. SPMS: Epidemiology and Market Forecasts to 2030 SPMS is characterized by a continuous increase in disability and worsening of symptoms with or without the period of relapses
Primary Progressive MS – Strong pipeline in progressive MS indicates a paradig …
Multiple Sclerosis is an autoimmune disorder that happens in the Central nervous system of the body. Multiple Sclerosis involves the brain, optic nerves and the spinal cord and leads to the destruction of the insulation layer, Myelin, which covers the nerve fibers in the CNS. Primary progressive multiple sclerosis is primarily characterized by progression of disease activity and the disability amongst the patients. As per the latest report by Pharmascroll, PPMS-
Primary Progressive Multiple Sclerosis Market Pegged For Robust Expansion During …
Multiple sclerosis (MS), which is also referred as disseminated sclerosis, is an inflammatory disease of the nervous system. It is mainly characterized by the disruption of the nerve cells of the spinal cord and the brain of an affected individual, which results in the loss of ability to communicate along with various other physical, mental as well as psychiatric problems. Primary Progressive Multiple Sclerosis (PPMS) is a type of MS
Primary Progressive Multiple Sclerosis (PPMS) - Market Insights, Emerging Therap …
Market Research HUBs Primary Progressive Multiple Sclerosis (PPMS) -Market Insights, Epidemiology and Market Forecast-2025 report provides an overview of the disease and in depth research related to Primary Progressive Multiple Sclerosis (PPMS) for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Primary
Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Insight and Therapeutic …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Primary Progressive Multiple Sclerosis (PPMS)-Pipeline Insight, 2017” to its report offerings. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1265527 The report provides comprehensive insights of the ongoing therapeutic research and development across Primary Progressive Multiple Sclerosis (PPMS). The report provides a complete